Clinical outcomes for previously treated patients with advanced biliary tract cancer - supplementary material

Supplemental Table 1: Search strategy for Embase (Embase 1974 to 2021 June 28)Supplemental Table 2: Search strategy for MEDLINE (Ovid MEDLINE In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) 1946 to June 28, 2021)Supplemental Table 3: Search strategy for CENTRAL (EBM Reviews - Cochrane Central Register of Controlled Trials May 2021)Supplemental Table 4: Search strategy for American Society of Clinical Oncology conference abstracts (Northern Light Life Sciences Conference Abstracts 2010 to 2021 Week 24)Supplemental Table 5: Search strategy for European Society for Medical Oncology conference abstracts (Northern Light Life Sciences Conference Abstracts 2010 to 2021 Week 24)Supplemental Table 6: Search strategy for ClinicalTrials.govSupplemental Table 7: Detailed study characteristics for trials included in the systematic reviewSupplemental Table 8: Detailed treatment characteristics for trials included in the systematic reviewSupplemental Table 9: Detailed patient characteristics for trials included in the systematic reviewSupplemental Table 10: Response outcomes for trials included in the systematic reviewSupplemental Table 11: Survival outcomes for trials included in the systematic reviewSupplemental Table 12: Safety outcomes for trials included in the systematic reviewSupplemental Table 13: Patient-reported outcomes for trials included in the systematic reviewSupplemental Table 14: Quality assessment of included single-arm and non-randomized trialsSupplemental Table 15: Summary of pooled KM estimates of OS Supplemental Table 16: Summary of KM estimates of PFS Supplemental Figure 1: Risk of bias assessment of included RCTs </p